Rilotumumab (Anti-HGF / SF)
Product Specifications
CAS Number
872514-65-3
Synonyms
AMG 102
Target
C-Met
Applications
Protein Tyrosine Kinase
Additionnal Information
Rilotumumab (Anti-HGF / SF) is a monoclonal antibody that inhibits HGF/MET-driven signaling. Rilotumumab shows anti-tumor activity, and can be used in castration-resistant prostate cancer (CRPC) and solid tumor research. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740177-500 1x 500 µL
CD50 (ICAM-3) (101-1D2), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040276-100 1x 100 µL
TAG-72 / CA72.4 (B72.3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041576-500 1x 500 µL
Cytokeratin, Basic (Type II or HMW) (Epithelial Marker) (KRTH/1576R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400760-100 1x 100 µL
Cytokeratin 7 (KRT7/760), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942066-500 1x 500 µL
CD45 / LCA (B-Cell Marker) (rPTPRC/1460), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details